Antibody Protein ELISA Kit from MyBioSource header Telephone 1.858.633.0165          
Fax 1.858.633.0166    Email 
menu1 Home Products Ordering Company Help menu7
   MyBioSource  rightarrow Blog  rightarrow KIAA2013 sirna  rightarrow LOG IN  rightarrow MY ACCOUNT  rightarrow CART CONTENTS  rightarrow CHECKOUT 
horiz bar
MyBioSource Blogs moreseparator
 • MARCO blocking peptide blog
 • ADPRM sirna blog
 • SPTBN1 blocking peptide blog
 • ADH/VP/AVP elisa kit blog
 • anti-NMDAR2B antibody blog
 • CHN2 positive control blog
 • anti-HSPA1L antibody blog
 • anti-TNFRSF1B antibody blog
 • PDIA3 elisa kit blog
 • SLC25A37 sirna blog
 • RLR elisa kit blog
 • TRAF6 shrna blog
 • anti-PRKDC antibody blog
 • GC elisa kit blog
 • SK-N-SH lysate blog
 • BTC sirna blog
 • MET blocking peptide blog
 • DPYSL3 sirna blog
 • FN1 secondary antibody blog
 • anti-Marburg Virus antibody blog
Blog Categories separator
 • Assay Kit Blogs
 • Biochemical Blogs
 • cDNA Clone Blogs
 • Monoclonal Antibody Blogs
 • Polyclonal Antibody Blogs
 • Rec/Purified Protein Blogs
 • Popular Product Blogs
Our Best Sellers moreseparator
 • Actin-like protein 7A (ACTL7A) Antibody
 • Troponin I-Cardiac (169-178 Region) (TNNI3) Antibody
 • A Disintegrin and Metalloprotease 2 (ADAM2) ELISA Kit
 • Growth Hormone ELISA Kit
 • b2-Microglobulin (HLA-G) Antibody
 • BID (Phospho-Ser78) Antibody
 • CLEC2D - OCIL - LLT1 Antibody
 • Luteinizing Hormone Native Protein
 • Myelin Basic Protein (MBP) ELISA Kit
 • CDC23 ELISA Kit
 • Hsp70 clone 3A3 Antibody
 • IgG (H+L) Secondary Antibody
 downarrow more ...

KIAA2013 sirna product blog

Posted on 2016-09-28 03:55:20 by mybiosource_staff
Share it on ...     
Tags: siRNA; KIAA2013; KIAA2013 sirna;
The KIAA2013 kiaa2013 (Catalog #MBS8205608) is a siRNA produced from Synthetic and is intended for research purposes only. The product is available for immediate purchase. The KIAA2013 siRNA (Human) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s KIAA2013 can be used in a range of immunoassay formats including, but not limited to, RNA Interference (RNAi). Researchers should empirically determine the suitability of the KIAA2013 kiaa2013 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.

The KIAA2013 kiaa2013 product has the following accession number(s) (GI #25286703) (NCBI Accession #NP_612355.1) (Uniprot Accession #Q8IYS2). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.

To buy or view more detailed product information and pricing, please click on the technical datasheet page below:

siRNA to inhibit KIAA2013 expression using RNA interference.

KIAA2013 kiaa2013

Quality Control: Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
Directions for Use: We recommends transfection with 100 nM siRNA 48 to 72 hours prior to cell lysis. Before resuspending, briefly centrifuge the tube to ensure the lyophilized siRNA is at the bottom of the tube. Resuspend the siRNA oligos to an appropriate concentration with DEPC water. For each vial, suitable for 250 transfections in 24 well plate (20 pmol for each well).
Components: We offer pre-designed sets of 3 different target-specific siRNA oligo duplexes of human KIAA2013 gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot. Our siRNA oligos are also chemically modified (2\'-OMe) at no extra charge for increased stability and enhanced knockdown in vitro and in vivo.
horiz bar
 SSL   Follow us on Facebook Follow us onTwitter Follow us on Google Plus Connect us on LinkedIn Subscribe to our RSS Feed for latest products and special promotions